ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection.
Bazzone LE, Zhu J, King M, Liu G, Guo Z, MacKay CR, Kyawe PP, Qaisar N, Rojas-Quintero J, Owen CA, Brass AL, McDougall W, Baer CE, Cashman T, Trivedi CM, Gack MU, Finberg RW, Kurt-Jones EA.
Bazzone LE, et al. Among authors: cashman t.
Nat Commun. 2024 May 16;15(1):4153. doi: 10.1038/s41467-024-48524-6.
Nat Commun. 2024.
PMID: 38755212
Free PMC article.